Nutil

Addiction

How addiction works, and what helps recovery

Understanding Addiction

Here's what science tells us about how addiction works and what helps.

How Addiction Works

The Reward System

Addictive substances hijack the brain's natural reward system[1]. The brain's dopamine system evolved to tag experiences as "worth repeating"—when you eat food or connect with friends, you get a small dopamine release. Drugs of abuse can create dopamine surges 2–10 times larger than natural rewards[2], essentially hijacking this system

Sugar activates reward circuits intensely—in rats, 94% preferred intense sweetness over cocaine[3]. The reward circuits respond intensely to concentrated sweetness, which may partly explain difficulties with sugar and processed food.

Tolerance and Withdrawal

With repeated use, the brain adapts[4]. The brain maintains balance (homeostasis), but when repeatedly flooded with a substance, it reduces its own production of similar chemicals and downregulates receptors:

Craving

Craving is triggered by stress and environmental cues[5]. A meta-analysis of 237 studies found that exposure to drug-associated cues more than doubles the odds of subsequent drug use or relapse[6].

Environmental triggers include:

These cues become conditioned through repeated pairing with substance use—the brain encodes them so that even after periods of abstinence, re-exposure can trigger strong cravings.

Behavioral Addictions

Addiction isn't limited to substances. Gaming addiction shows measurable brain changes[7].

Behavioral addictions share key features with substance addictions[8]:

Common behavioral addictions[9]:

Is Addiction a "Brain Disease"?

The idea that addiction is a brain disease—championed by the U.S. National Institute on Drug Abuse (NIDA)—has been influential in shifting policy from punishment toward treatment. But the "brain disease model" is scientifically contested, and the debate matters for how we understand and treat addiction.

Arguments for the brain disease model:

Arguments against (or questioning) the brain disease model:

Many researchers now advocate a biopsychosocial model that recognizes addiction involves brain changes, learned behaviors, social context, and individual agency[16]—not reducible to any single factor.

What Helps Recovery

Social Support

Changing social networks is crucial for recovery[17].

What helps:

Treatment Works

Treatment engagement reduces harm[20].

Effective treatments include:

Mindfulness and Attention Training

A systematic review of mindfulness-based programs for substance use disorders found they reduce cravings, decrease frequency and quantity of use, and improve co-occurring symptoms like anxiety and depression[24]. Mindfulness-Based Relapse Prevention (MBRP) — the most studied protocol — performs comparably to established therapies like CBT, and may be particularly effective for craving reduction and long-term relapse prevention.

Randomized trials confirm mindfulness training improves decision-making, inhibitory control, and reduces impulsivity[25] in people with substance use disorders. A related approach is cognitive bias modification — retraining the automatic attention and action tendencies that draw people toward substance-related cues. A multicenter RCT (169 participants) tested attentional bias modification training as an add-on to regular treatment for alcohol and cannabis use disorders[26], but found no significant differences in substance use, craving, or relapse at follow-up — suggesting this particular approach may not target the right cognitive mechanism. However, a different technique — approach-bias retraining, where patients practice pushing away alcohol-related images with a joystick — has shown more promise, with RCTs finding it reduces relapse rates by roughly 8–10% in the first year when added to standard treatment.

Recovery Narratives

Recovery stories share these common themes:

The Recovery Cascade

Williams et al. mapped a "cascade of care" for opioid use disorder[28] — borrowing the concept from HIV treatment — tracking how many people progress through each stage from identification to sustained recovery. They found large drop-offs at every step, showing that getting someone into treatment once is not enough.

Recovery is rarely linear. Most people:

Myths About Addiction

Myth: Addiction is a choice
Reality: Initial use may be a choice, but addiction changes brain circuitry in ways that impair decision-making and impulse control.
Myth: You have to hit "rock bottom"
Reality: Earlier intervention is more effective. Waiting for catastrophe causes unnecessary harm.
Myth: Relapse means failure
Reality: Relapse is common and doesn't erase progress. Rates are similar to other chronic diseases like diabetes.
Myth: Willpower is enough
Reality: Treatment, support systems, and often medication are far more effective than "just stopping."

Harm Reduction

Harm reduction accepts that some drug use will occur and focuses on minimizing negative consequences rather than requiring abstinence. Evidence consistently shows these approaches save lives without increasing drug use or crime rates[29].

---

References

Systematic review / meta-analysis Randomised controlled trial Published study Low quality / unsupported
  1. ['Badiani A', 'Belin D', 'Bhutton M', 'Drummond D', 'Robinson T'] (2007). The Mechanistic Classification of Addictive Drugs. PLOS Medicine. [DOI]
  2. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011). Addiction: Beyond dopamine reward circuitry. Proceedings of the National Academy of Sciences. [DOI]
  3. ['Lenoir M', 'Serre F', 'Cantin L', 'Ahmed SH'] (2007). Intense Sweetness Surpasses Cocaine Reward. PLOS ONE. [DOI]
  4. Koob GF, Volkow ND (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry. [DOI]
  5. ['Nakagawa T', 'Kondo S', 'Takebayashi Y'] (2021). A mindfulness-based, stress and coping model of craving in methamphetamine users. PLOS ONE. [DOI]
  6. Vafaie N, Kober H (2022). Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. JAMA Psychiatry. [DOI]
  7. ['Yuan K', 'Cheng P', 'Dong T', 'Bi Y', 'Xing L', 'Yu D'] (2012). Cortical Thickness Abnormalities in Late Adolescence with Online Gaming Addiction. PLOS ONE. [DOI]
  8. Grant JE, Brewer JA, Potenza MN (2006). The neurobiology of substance and behavioral addictions. CNS Spectrums. [DOI]
  9. Potenza MN, Balodis IM, Derevensky J, Grant JE, Petry NM, Verdejo-Garcia A, Yip SW (2024). Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice. American Journal of Psychiatry. [DOI]
  10. Verweij KJH, Zietsch BP, Lynskey MT, Medland SE, Neale MC, Martin NG, Boomsma DI, Vink JM (2010). Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction. [DOI]
  11. Lopez-Quintero C, Hasin DS, de los Cobos JP, Pines A, Wang S, Grant BF, Blanco C (2011). Probability and predictors of remission from life-time nicotine, alcohol, cannabis, or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction. [DOI]
  12. Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ (2021). Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. [DOI]
  13. Blithikioti C, Nutt DJ, Munafò MR (2025). Reevaluating the brain disease model of addiction. The Lancet Psychiatry. [DOI]
  14. Wiers RW, Gladwin TE, Rinck M (2025). The compulsive brain disease model of addiction lowers self-efficacy. International Journal of Mental Health and Addiction. [DOI]
  15. Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ (2021). Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. [DOI]
  16. Blithikioti C, Nutt DJ, Munafò MR (2025). Reevaluating the brain disease model of addiction. The Lancet Psychiatry. [DOI]
  17. ['Kelly JF', 'Stout RL', 'Magill M', 'Tonigan JS', 'Pagano ME'] (2014). Young Adults, Social Networks, and Addiction Recovery: Post Treatment Changes in Social Ties and Their Role as a Mediator of 12-Step Participation. PLOS ONE. [DOI]
  18. Kelly JF, Humphreys K, Ferri M (2020). Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews. [DOI]
  19. Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A (2016). Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review. Journal of Substance Abuse Treatment. [DOI]
  20. ['Chang Z', 'Lichtenstein P', 'Långström N', 'Larsson H', 'Fazel S'] (2015). Mental Health Services and Public Safety: Substance Abuse Outpatient Visits Were Associated with Reduced Crime Rates in a Swedish Cohort. PLOS ONE. [DOI]
  21. McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, Coffey CP, Edlund MD, Bobashev G, Jonas DE (2023). Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA. [DOI]
  22. Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll K (2019). A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of Consulting and Clinical Psychology. [DOI]
  23. de Andrade D, Elphinston RA, Quinn C, Allan J, Hides L (2019). The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review. Drug and Alcohol Dependence. [DOI]
  24. Korecki JR, Schwebel FJ, Votaw VR, Witkiewitz K (2020). Mindfulness-based programs for substance use disorders: a systematic review of the evidence. Substance Abuse Treatment, Prevention, and Policy. [DOI]
  25. ['Kianersi S', 'Semnani Y', 'Nazari MA', 'Moulodi F'] (2023). The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial. PLOS ONE. [DOI]
  26. ['Boffo M', 'Willemen L', 'Pronk T', 'Wiers RW'] (2021). Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial. PLOS ONE. [DOI]
  27. ['Parkman T', 'Lloyd C', 'Spilsbury K'] (2022). Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis. PLOS ONE. [DOI]
  28. ['Williams AR', 'Nunes EV', 'Bisaga A', 'Levin FR', 'Olfson M'] (2019). Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment. PLOS Medicine. [DOI]
  29. Pridgen Bailey E, Bontemps AP, Lloyd AR, Wagner WP, Kay ES (2025). U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and evidence-based strategies. Harm Reduction Journal. [DOI]
  30. Various (2023). The Impact of Needle and Syringe Exchange Programs on HIV-Related Risk Behaviors and Outcomes in People Who Inject Drugs: A Systematic Review and Meta-Analysis. AIDS and Behavior. [DOI]
  31. Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L (2019). Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry. [DOI]
  32. Various (2025). Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs. JAMA Network Open. [DOI]
  33. Various (2021). Supervised Injection Facilities as Harm Reduction: A Systematic Review. American Journal of Preventive Medicine. [DOI]